A NEW ERA OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITION IN CHOLANGIOCARCINOMA

被引：2
|
作者：
Lamarca, A. [1 ,2 ]
Moreno, V. [3 ]
Gambardella, V. [4 ,5 ]
Cervantes, A. [4 ,5 ]
机构：
[1] Fdn Jimenez Diaz Univ Hosp, Oncohealth Inst, Dept Med Oncol, Madrid, Spain
[2] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, England
[3] Fdn Jimenez Diaz Univ Hosp, Dept Med Oncol, START FJD Phase Unit 1, Madrid, Spain
[4] Univ Valencia, Hosp Clin Univ, INCLIVA Biomed Res Inst, Valencia, Spain
[5] Inst Salud Carlos III, CIBERONC, Madrid, Spain
来源：
ESMO OPEN | 2023年 / 8卷 / 06期
关键词：
METASTATIC CHOLANGIOCARCINOMA; OPEN-LABEL; MULTICENTER; EFFICACY;
D O I：
10.1016/j.esmoop.2023.102032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Genetic determinants of response to fibroblast growth factor receptor inhibitors in solid tumours
    Leroy, Laura
    Cousin, Sophie
    Italiano, Antoine
    EUROPEAN JOURNAL OF CANCER, 2017, 81 : 102 - 105
  • [22] Fibroblast growth factor in the treatment of burns: A systematic review
    Gragnani, A.
    Tonarelli, E.
    Chomiski, V.
    Daher, R. Piccolo
    Ferreira, L. M.
    BURNS, 2022, 48 (01) : 104 - 110
  • [23] Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor-Amplified Gastroesophageal Cancer: Retrospective Global Experience
    Maron, Steven B.
    Moya, Stephanie
    Morano, Federica
    Emmett, Matthew J.
    Chou, Joanne F.
    Sabwa, Shalom
    Walch, Henry
    Peterson, Bryan
    Schrock, Alexa B.
    Zhang, Liangliang
    Janjigian, Yelena Y.
    Chalasani, Sree
    Ku, Geoffrey Y.
    Disel, Umut
    Enzinger, Peter
    Uboha, Nataliya
    Kato, Shumei
    Yoshino, Takayuki
    Shitara, Kohei
    Nakamura, Yoshiaki
    Saeed, Anwaar
    Kasi, Pashtoon M.
    Chao, Joseph
    Lee, Jeeyun
    Capanu, Marinela
    Wainberg, Zev
    Petty, Russell
    Pietrantonio, Filippo
    Klempner, Samuel J.
    Catenacci, Daniel V. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (22) : 2458 - +
  • [24] Local Delivery of Gemcitabine Inhibits Pancreatic and Cholangiocarcinoma Tumor Growth by Promoting Epidermal Growth Factor Receptor Degradation
    Jang, Sung Ill
    Fang, Sungsoon
    Baek, Yi-Yong
    Lee, Don Haeng
    Na, Kun
    Lee, Su Yeon
    Lee, Dong Ki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (05)
  • [25] Targeting Fibroblast Growth Factor Receptor Pathway: Precision Medicine for Biliary Cancer and Beyond
    Uson Jr, Pedro Luiz Serrano
    Borad, Mitesh J.
    SEMINARS IN LIVER DISEASE, 2023, 43 (02) : 218 - 225
  • [26] Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer
    Miao, Jian-Long
    Liu, Rui-Juan
    Zhou, Jin-Hua
    Meng, Shu-Hua
    CHINESE MEDICAL JOURNAL, 2016, 129 (23) : 2868 - 2872
  • [27] Epidermal Growth Factor Receptor Inhibition in Lung Cancer Status 2012
    Hirsch, Fred R.
    Jaenne, Pasi A.
    Eberhardt, Wilfried E.
    Cappuzzo, Federico
    Thatcher, Nick
    Pirker, Robert
    Choy, Hak
    Kim, Edward S.
    Paz-Ares, Luis
    Gandara, David R.
    Wu, Yi-Long
    Ahn, Myung-Ju
    Mitsudomi, Tetsuya
    Shepherd, Frances A.
    Mok, Tony S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 373 - 384
  • [28] Epidermal Growth Factor Receptor Mutations
    McLoughlin, Erin M.
    Gentzler, Ryan D.
    THORACIC SURGERY CLINICS, 2020, 30 (02) : 127 - 136
  • [29] Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung
    Goss, Glenwood D.
    Spaans, Johanna N.
    ONCOLOGIST, 2016, 21 (02) : 205 - 213
  • [30] Epidermal Growth Factor Receptor Inhibition in Squamous Cell Carcinoma of the Head and Neck
    Machiels, Jean-Pascal
    Schmitz, Sandra
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (06) : 1011 - +
12345